Uncovering Hidden ERP Implementation Costs Through Life Science Industry Analysis

Introduction:

Enterprise resource planning (ERP) systems integrate core business activities such as finance, purchasing, inventory, manufacturing and supply chain management into a shared technology environment. For life sciences organizations, however, the cost of implementation can extend well beyond the initial software and consulting estimates.

Pharmaceutical manufacturers, biotechnology companies and medical device manufacturers operate under requirements that place greater emphasis on traceability, data integrity, quality controls and documented processes. As a result, an ERP for life sciences may require additional validation, testing, documentation and integration work before it can support regulated operations.

The difference between the initial project budget and the eventual total investment often comes from these less visible activities. Examining real implementation experiences helps healthcare professionals understand where those costs emerge and how they can affect operational risk.

Where Hidden ERP Costs Emerge

ERP implementation expenses often extend beyond the initial technology and service estimates. In life sciences, regulatory requirements, complex data and interconnected systems can introduce additional work before and after go-live. Identifying these cost drivers early gives organizations a clearer view of the resources required for a successful implementation.

Regulatory Validation and Documentation

Regulatory compliance can become one of the largest differences between a conventional ERP rollout and an implementation in a regulated environment. Computer system validation (CSV) is the documented process used to demonstrate that a computerized system performs consistently and as intended for its regulated use.

More recently, the Food and Drug Administration (FDA) has promoted a risk-based approach called computer software assurance (CSA), which focuses testing and evidence on the potential impact of software functions rather than applying identical testing to every feature.

The FDA's February 2026 guidance recommends risk-based computer software assurance for software used in medical device production and quality management systems (FDA, 2026). This means implementation teams may need to perform risk assessments, define requirements, document testing and maintain evidence that critical functions operate appropriately.

Electronic records can create another layer of work. Under 21 CFR Part 11, electronic records and electronic signatures within its scope must meet requirements intended to ensure they are trustworthy and reliable (Yale University Human Research Protection Program, 2025). Organizations then need to determine which ERP records are subject to applicable regulatory requirements and establish appropriate controls. These activities consume personnel time even when they do not appear as conventional software costs.

Data Migration

Data migration involves transferring information from existing applications into the new ERP. In life sciences, migration can be more complicated because organizations may need to preserve product, supplier, customer, batch, lot, serial-number and quality information.

Poor-quality legacy data can further increase costs. Duplicate records, inconsistent naming conventions, or incomplete histories may need to be identified and corrected before migration. Retaining every historical record is not necessarily the best approach either. Organizations may determine that some information should remain in an archive rather than be transferred to the operational ERP.

A case study of a medical device manufacturer implementing Oracle Cloud ERP illustrates this issue. The organization was working with multiple legacy systems and significant amounts of manually maintained information. The implementation reported a 40% reduction in data migration effort after adopting structured implementation tools and processes (LTM, 2024). The example demonstrates that migration is not simply a technical transfer. The effort required to prepare information can materially affect project economics.

Integration and Customization

ERP systems rarely operate alone. Life sciences companies may need connections to laboratory systems, manufacturing execution systems, warehouse systems, electronic data interchange (EDI), customer platforms and quality management systems.

An application programming interface (API) is a structured mechanism that allows two software systems to exchange information. Each integration can require design, development, testing, security controls and ongoing maintenance.

Customization can create another recurring expense. A business may initially request modifications so the ERP mirrors an existing process. While this can solve an immediate operational problem, extensive customization can increase testing requirements and complicate future upgrades. The financial impact, therefore, extends beyond the original implementation. Every customized workflow or integration can become part of the system's long-term maintenance burden.

What Implementation Experience Reveals

Real-world ERP implementations show how costs can emerge at different stages of a project, from regulatory preparation and data migration to integration and operational continuity. The following cases illustrate these challenges across regulated and complex industries, highlighting practical considerations for organizations planning their own ERP investments.

Safecor Health: Regulatory Requirements Can Expand ERP Costs

Safecor Health, a pharmaceutical manufacturer and repackager, faced new Drug Supply Chain Security Act (DSCSA) requirements that made product serialization necessary. Strategic Information Group noted that the initial approach was expected to take nearly two years and require stand-alone applications outside its QAD ERP system, adding implementation, integration and maintenance costs (Strategic Information Group, 2024).

The project instead incorporated electronic data interchange (EDI), scanning and label-printing processes into the existing ERP environment. The solution also captured serial information at frequent intervals to meet the requirements of the pharmaceutical supply chain (Strategic Information Group, 2024).

The case shows how regulatory changes can expand ERP costs beyond software configuration. EDI connections, specialized workflows, testing, validation and ongoing support can all affect the total investment required for compliance.

Maersk: Migration Can Create Operational Costs

Maersk's transition to SAP S/4HANA illustrates how ERP migration can affect operations beyond the implementation budget. During its 2024 transition, the company temporarily suspended MyFinance functions, including invoice downloads, disputes, refunds and payments, creating potential delays for customers (Maersk, 2024).

The example highlights why business continuity should be included in ERP cost planning. Temporary workarounds, additional staffing, downtime and post-migration support can create expenses that are not reflected in the initial technology estimate.

For life sciences organizations, the same consideration can apply to systems supporting inventory, production or distribution. Even a planned transition can require contingency measures when essential processes depend on the ERP system.

Zimmer Biomet — Implementation Issues Can Affect Revenue

Medical device manufacturer Zimmer Biomet provides a more direct example of operational ERP risk. In 2024, the company reported disruptions linked to an ERP implementation affecting accounting and supply chain activities (Reuters, 2024).

The company subsequently estimated that the ERP issues would reduce annual revenue by about 1%. This demonstrates how implementation problems can create financial consequences beyond software, consulting and deployment costs (Reuters, 2024).

For regulated manufacturers, the potential impact can extend to order processing, production planning and inventory availability. Including these risks in implementation planning can provide a more complete view of the project's potential financial exposure.

Building a More Complete ERP Cost Model

A more realistic implementation budget should separate visible project costs from life cycle costs. Key cost categories to consider include:

• Software and infrastructure: Organizations should account for subscriptions, licenses, environments, storage and related technology services.
• Implementation services: This category can include process analysis, configuration, project management, integration development and technical work.
• Validation and quality: Regulated organizations should budget for risk assessments, requirements documentation, test execution, traceability and validation or assurance activities appropriate to the system's intended use.
• Data preparation and migration: Costs can include data cleansing, mapping, conversion, reconciliation and archival decisions.
• Integration: Every connection to another system should be evaluated for development, testing, monitoring and future maintenance requirements.
• Training and change management: Employees need time to learn new workflows, while subject-matter experts may need to participate in testing and process design. Change management refers to the structured process of preparing people and operations for new ways of working.
• Business continuity: Organizations should estimate the cost of temporary workarounds, downtime, additional staffing and contingency procedures.
• Post-go-live support: The first weeks or months after launch can require additional technical support, issue resolution and process adjustments. Organizations should also consider recurring costs for upgrades, integrations, validation, maintenance and system administration.

Evaluating ERP Partners Through Total Cost of Ownership

Healthcare organizations evaluating implementation partners should look beyond hourly rates or initial project estimates. Total cost of ownership (TCO) describes the full cost of acquiring, implementing, operating and maintaining a system over its useful life.

For organizations comparing the best NetSuite implementation partners for life sciences companies, relevant evaluation criteria may include experience with regulated manufacturing, validation capabilities, integration expertise, data migration methodology and post-implementation support. The implementation approach should account for the operational and regulatory environment in which the system will function.

A lower initial estimate can become less economical if it excludes validation work, assumes clean data or treats integrations as minor additions. Conversely, a more comprehensive initial plan may appear more expensive while reducing the likelihood of unplanned work later.

A Life Cycle View of ERP Investment

ERP implementation in life sciences should be evaluated as a life cycle rather than a single technology purchase. The initial implementation represents only one stage. Data quality, regulatory requirements, integrations, employee adoption, system changes and ongoing support can continue affecting costs for years.

The experiences of Safecor Health, Maersk and Zimmer Biomet show three different dimensions of this problem. Regulatory requirements can expand implementation scope, migration can temporarily disrupt operations and technical problems can translate directly into lost revenue.

For healthcare professionals involved in ERP decisions, the practical lesson is to build budgets around the full operating environment. A complete cost model should identify what the system costs to install as well as what the organization must do to validate it, connect it, operate through the transition and maintain it as regulatory and business requirements change.